Image courtesy of Amen Clinics
May 10, 2019 — Shine Medical Technologies Inc. broke ground on their firstmedical isotopeproduction facility in Janesville, Wis. U.S. Department of Energy (DOE) Under Secretary for Nuclear Security and Administrator of the National Nuclear Security Administration (NNSA) Lisa Gordon-Hagerty, Lantheus Medical Imaging President and CEO Mary Heino and Janesville City Manager Mark Freitag joined Shine founder and CEO, Greg Piefer, and the Shine team to celebrate the milestone.
The groundbreaking follows the recent transfer of 91 acres of land from the City of Janesville located across from the Southern Wisconsin Regional Airport. Once complete, the 43,000-square-foot facility will be home to eight of Shine’s accelerator-based medical isotope production systems, capable of producing more than one-third of global demand for the medical isotope molybdenum-99 (Mo-99). Shine currently employs more than 90 people and expects to hire approximately 60 more before the completion of the facility.
“I am very proud of the role NNSA has played in our public-private partnership with SHINE,” Gordon-Hagerty said. “Not only are we assisting in saving lives, but we are promoting the elimination of material in civilian applications that might otherwise fall into an adversary’s hands for use in a terrorist threat. DOE/NNSA looks forward to celebrating future successes together.”
钼的国内生产多年来一直是一个重要的课题。钼-99 (Mo-99)是锝-99m (Tc-99m)的前体元素，锝-99m是医学成像中使用最广泛的放射性同位素。在2018年之前，Mo-99只能由美国以外的设施从浓缩铀中生产。这需要一个复杂的供应链，涉及从美国运输浓缩铀。根据美国食品和药物管理局(FDA)和核管理委员会(NRC)，这使美国容易受到可能的短缺和/或供应链问题。The situation became more urgent in 2016 when Chalk River Laboratories (CRL), the Canadian facility that was the world’s largest production reactor for medicalnuclear imagingisotopes, ceased production of Mo-99.
Last year, the FDA cleared the way for the first domestic supply of Tc-99m with the approval of the NorthStar Medical Radioisotopes’ RadioGenix System, which produces Mo-99.
For more information:www.shinemed.com
Related Mo-99 Content
August 10, 2022
